LFSC

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.02
Percentage change 0.07	%

Category	US Equities - Factor & Thematic	Asset Type	Equities (Stocks)	Tags	Developed	Return% 1Y	-	Total Holdings	34	Perf Week	0.65%
Sponsor	F/m Investments	ETF Type		Tags	equity	Return% 3Y	-	AUM	56.23M	Perf Month	10.21%
Fund Family		Bond Type		Tags	innovation	Return% 5Y	-	NAV/sh		Perf Quarter	8.92%
Index	-	Average Maturity		Tags	healthcare	Return% 10Y		52W High	27.76 -10.55%	Perf Half Y	-2.95%
Index Weighting		Commodity Type		Tags	biotechnology	Return% SI		52W Low	18.78 32.22%	Perf YTD	6.15%
Active/Passive		Quant Type		Tags	medical	Flows% 1M	1.28%	Volatility	0.36% 0.67%	Perf Year	-
Dividend TTM	-	ESG Type		Tags	pharmaceutical	Flows% 3M	2.45%	ATR (14)	0.32	Perf 3Y	-
Dividend Ex-Date	-	Dividend Type		Sector/Theme		Flows% YTD	8.64%	RSI (14)	61.69	Perf 5Y	-
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	-	Perf 10Y	-
Expense	0.54%	Growth/Value		SMA20	1.65%	Flows% 3Y		Rel Volume	0.01	Prev Close	24.81
Inverse/Leveraged		Market Cap		SMA50	7.94%	Flows% 5Y		Avg Volume	2.97K	Price	24.83
IPO	Oct 31, 2024	Option/Short	No / No	SMA200	2.75%	Trades		Volume	18	Change	0.07%

Feb-04-25 10:15AM	Shining a Light on New Investment Opportunities: Small Caps Emerge from the Shadows at the Groundhog Investment Conference (Business Wire)
Oct-31-24 07:30AM	Emerald Advisers and F/m Investments Announce the Launch of the F/m Emerald Life Sciences Innovation ETF (LFSC) (Business Wire)

F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

open in yahoo | open in marketwatch | open in google

F/m Emerald Life Sciences Innovation ETF

Upgrade your FINVIZ experience